Fuse Medical, Inc.
FZMD
$0.062
-$0.0279-31.03%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.05% | -12.51% | -19.35% | 6.73% | -17.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.05% | -12.51% | -19.35% | 6.73% | -17.59% |
| Cost of Revenue | -24.66% | -32.98% | -10.65% | -20.41% | -8.61% |
| Gross Profit | 31.41% | 0.18% | -25.65% | 27.88% | -23.38% |
| SG&A Expenses | 6.26% | -8.30% | -23.18% | -4.17% | -25.14% |
| Depreciation & Amortization | -4.94% | -2.91% | -524.88% | 466.90% | 121.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.49% | -16.88% | -20.00% | -8.92% | -18.74% |
| Operating Income | 231.19% | 62.24% | 25.92% | 106.59% | 33.99% |
| Income Before Tax | 199.06% | 52.75% | 1,127.20% | 99.70% | -293.80% |
| Income Tax Expenses | 38.46% | 14.29% | 28.00% | 108.57% | 8.33% |
| Earnings from Continuing Operations | 195.26% | 52.06% | 1,110.82% | 98.65% | -277.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 195.26% | 52.06% | 1,110.82% | 98.65% | -277.66% |
| EBIT | 231.19% | 62.24% | 25.92% | 106.59% | 33.99% |
| EBITDA | 262.72% | 67.29% | 28.89% | 119.07% | 39.88% |
| EPS Basic | 195.65% | 52.94% | 1,112.00% | 98.99% | -283.33% |
| Normalized Basic EPS | 200.00% | 52.38% | 21.31% | 100.00% | 28.21% |
| EPS Diluted | 184.78% | 52.94% | 812.00% | 98.99% | -283.33% |
| Normalized Diluted EPS | 189.29% | 52.38% | 44.26% | 100.00% | 28.21% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | -0.42% | 0.14% | 0.14% |
| Average Diluted Shares Outstanding | 10.96% | 0.00% | 42.28% | 0.14% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
